Skip to main content
Premium Trial:

Request an Annual Quote

Gentris Taps BioFortis' Software to Manage Biorepository Data

Premium

Gentris has selected BioFortis' Labmatrix and Qiagram software to manage samples and data collection and integration activities in its biorepository.

BioFortis' Labmatrix and Qiagram software were developed to integrate and query information from multiple sources including biomarker, translational, clinical, and healthcare data. They will provide Gentris' clients with tools to view and manage samples housed in the Gentris biorepository as well as enable them collect, harmonize, and integrate multiple data types including clinical, molecular, patient, and biospecimen data.

The financial details of the agreement were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.